Email a Friend
Print ArticleBreast Cancer Health Center
Breast Cancer and Mammogram Results
What if the radiologist sees something suspicious or abnormal on your mammogram? The fear of abnormal mammogram results is real, but facts may help calm it. Most abnormalities found in mammogram results are not breast cancer.
The American Cancer Society recommends yearly screening mammograms starting at age 40. However, the U.S. Preventive Services Task Force (USPSTF) does not recommend screening for women in their 40s. For women between the ages of 50 and 74, USPSTF experts say women should have mammograms every two years and do not recommend screening at all after age 74.
Questionable mammogram results sometimes require additional testing. With further examination (imaging studies and/or biopsy), most of these abnormalities are found to be normal breast tissue or benign (non-cancerous) tissue.
What Is a Screening Mammogram?
Screening mammograms are recommended each year for all women starting at age 40, even if they have no signs or symptoms of breast disease.
In a screening mammogram, each breast is X-rayed in two different positions: from top to bottom and from side to side. When a mammogram image is viewed, breast tissue appears white and opaque and fatty tissue appears darker and translucent.
What if Something Looks Abnormal on a Mammogram?
Potential abnormalities are found in 6% to 8% percent of women who have screening mammograms. This small group of women needs further evaluation that may include diagnostic mammography, breast ultrasound, or needle biopsy.
After the additional evaluation is complete, most of these women will be found to have nothing wrong.
What Is a Diagnostic Mammogram?
Diagnostic mammograms differ from screening mammograms in that the exam focuses specifically on an area of tissue that appeared abnormal in a screening mammogram. Diagnostic mammograms are also done for women who haven't had a screening mammogram but may be showing signs or symptoms of something abnormal in the breasts.
Depending on the potential abnormality, different studies may be done. In some women, only additional images are needed. In other women, additional images and a breast ultrasound are done.
How Does an Abnormality Appear on a Mammogram?
A potential abnormality on a mammogram may be called a nodule, mass, lump, density, or distortion.
- A mass (lump) with a smooth, well-defined border is often benign. Ultrasound is needed to characterize the inside of a mass -- if the mass contains fluid, it is called a cyst.
- A mass (lump) that has an irregular border or a star-burst appearance (spiculated) may be cancerous and a biopsy is usually recommended.
- Microcalcifications (small deposits of calcium) are another type of abnormality. They can be classified as benign, suspicious, or indeterminate. Depending on the appearance of the microcalcifications on the additional magnified images, a biopsy may be recommended.
How Accurate Is Mammography?
Mammography is 85% to 90% accurate. Mammograms have improved the ability to detect breast abnormalities before they are large enough to be felt during a breast examination.
However, it is possible for a mass to be felt but not appear on a mammogram. Because of this, your health care provider should evaluate any abnormality that you feel when examining your breasts. A diagnostic mammogram or additional studies may be recommended.
WebMD Medical Reference
Breast Cancer Guide
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.
October is National Breast Cancer Awareness Month, and a new study reveals why a high number of women with the disease still prefer to have the entire breast surgically removed instead of just the tumor. It's not always because doctors recommend it.
